Aggarwal Sumit bought ELOX

October 16, 2024 · Form 4 insider transaction

Aggarwal Sumit bought 35,580 shares of Eloxx Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 569 days after the transaction.

Direction
Acquired (buy-side)
Shares
35,580
Price
N/A
Total value
N/A
RoleOfficer, Director, 10% owner
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 16, 2024
Filing dateMay 8, 2026
Shares owned after35,580
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The reporting person agreed to cancellation of an option granted to him on April 1, 2021 in exchange for a new option having a lower exercise price.; The stock option vested and became exercisable over the four-year period commencing April 1, 2021, with one-fourth of the shares of common stock underlying the options vesting on April 1, 2022, and the remainder vesting in twelve equal quarterly installments thereafter.

View the original Form 4 on SEC EDGAR